Warnings and Precautions 5.1 Diabetic Ketoacidosis in Patients with Type 1 Diabetes Mellitus and Other Ketoacidosis In patients with type 1 diabetes mellitus, FARXIGA significantly increases the risk of diabetic ketoacidosis, a life-threatening event, beyond the background rate
Tammadon MR, Nobahar M, Hydarinia-Naieni Z, Ebrahimian A, Ghorbani R, Vafaei AA (2021) The effects of valerian on sleep quality, depression, and state anxiety in hemodialysis patients: a randomized, double-blind, crossover clinical trial
99% purity is essential for MC1R receptor pharmacology, melanogenesis signal transduction studies, photoprotection biology research, and MC1R polymorphism characterisation where impurities including partially oxidised or degraded peptide fragments would show altered receptor binding and confound dose-response characterisation
According to research, raising the overall carnitine level may change two distinct aspects of training-related muscle fuel consumption